Questions about the $5m raise increase

This article is brought to you by Equifund Technologies, LLC.

Share on facebook
Share on twitter
Share on linkedin

We’ve had a few people write in asking questions about the new $5 million raise cap for Reg-CF offers that goes into effect on Monday…

And if existing Reg-CF offers will automatically be able to raise up to $5m.

Here’s the short answer: No.

Here’s the medium answer: The issuer would need to amend their existing offering by filing a Form-C/A with the SEC to increase the amount they want to raise.

However, because this would constitute a “material change” in the offering, the issuer would need to reconfirm all investments that haven’t already been closed (more on this in another email).

Here’s the longer answer: Depending on a lot of factors, it might not make sense for an issuer to raise more money, regardless of the increase.


Well, it all comes back to the critical questions every business must answer when raising capital…

What is the Cost of Capital?

Here’s what I mean…

In the same way you can go to the supermarket (or grocery store) to buy groceries…

You can go to the Capital Markets to buy money.

And there’s no shortage of vendors who are willing to “sell” you their money…

But, in exchange for what?

It’s called a Financial Instrument. 

In the same way a business can sell its products and services – or an asset it owns – to “raise capital” (i.e. generate revenue)…

It can sell a Financial Instrument as well. These financial instruments include equity, debt, and exotics such as derivatives, coins, or SAFEs.

Every issuer has to decide if the Cost of Capital – which is what they have to “sell” to get the money they need – is worth it for where their business is right now…

Or if they’d be better off increasing their valuation by hitting milestones so they can raise capital at more favorable rates or with less dilution.

Understanding this dynamic is really important for you as a private market investor.

Whether you realize it or not… as an investor, you are now a “vendor” in the Capital Markets. 

And if you want your “business” to make money, it means you need to know what type of financial instruments are out there (equity, debt, and exotics)…

You need to understand how to value those financial instruments (i.e. “valuation”)…

You need to understand how those financial instruments are allegedly supposed to perform (i.e. the risk:reward ratio)…

And more important, you have to determine if those financial instruments will help you reach your own personal financial goals.

Eventually, this means you need to have a durable process for finding the right deals and doing proper due diligence.

Of course, that’s our goal here at Equifund — to present you with vetted private market opportunities and help educate you so you can make better investment decisions.


Jake Hoffberg

Jake Hoffberg – Publisher

Like this article? Share it with a friend:

Share on facebook
Share on twitter
Share on linkedin

This article is not an Equifund Crowd Funding Portal Inc communication. It is brought to you by Equifund Technologies, LLC.

More Articles:

Buy a mining claim

How to Buy a Mining Claim in 2023

Mining claims give individuals the legal right to explore and extract valuable minerals like gold from public land. Here are the steps involved in staking, filing, and selling mining claims in 2023—with a particular focus on Nevada gold mines.

Don't make another private market investment without reading this...

The 5 Mistakes

investors make that crush returns

Download this free report now:

Just enter your name & email to access this report for free.

By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.

More Articles:


Kleiner Device Labs

Investment Highlights:

  • 1

    Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.

  • 2

    Over 20 patents have been issued to protect the company's technologies.

  • 3

    Just received FDA clearance for their next-generation KG2 spinal fusion technology.

Pre-Investment Agreement

The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO

Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:

    • Received and have reviewed the education materials sent to you.
    • UNDERSTAND; that there are restrictions on your ability to cancel your investment commitment and obtain a return of your investment.
    • KNOW; It may be difficult to resell securities acquired under Regulation Crowdfunding.
    • AGREE; investing in securities offered and sold in reliance on section 4(a)(6) of the Securities Act involves risk. Investors should not invest any funds unless he or she can afford to lose the entire amount of his or her investment. Your investment may not work out, and you must be in a financial condition to bear the loss.
  • Hidden
  • Hidden
  • Hidden
  • Hidden

We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.

Complete Your Registration

By verifying your account you agree with our terms of use, privacy policy and pre-dispute arbitration agreement. Please complete the registration process by clicking the link below:

Verify Your Email

Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.

If you have not received the email in 5 minutes, please click here to have it resent.

Questions? Our customer service team is always here to help – 1-866-338-3004

Enter your email address to get instant access to the video: